CTOs on the Move


 
Ivenix, Inc. is a venture-backed medical device company with a vision to transform infusion delivery in every care setting, globally. The company is focused on bringing its first product to market, a new and innovative infusion management system for hospitals. The system combines integrated state-of-the-art information technology and simplicity with an adaptive fluid delivery platform that continuously measures flow. The company is headquartered in Amesbury, Massachusetts.
  • Number of Employees: 25-100
  • Annual Revenue: $0-1 Million
  • www.ivenix.com
  • 21 Water St
    Amesbury, MA USA 01913
  • Phone: 978.792.5000

Executives

Name Title Contact Details

Funding

Ivenix raised $42M on 09/01/2015

Similar Companies

Abridge

Abridge helps people stay on top of their health, one conversation at a time. We help people capture the details of their care so they can follow through on doctor`s recommendations and gain more peace of mind throughout their health journey.

Clinipace

At Clinipace, a global, full-service contract research organization (CRO), our approach to clinical research is personal. We deliver a level of collaboration and flexibility not possible in a traditional CRO environment. Our personalized services and solutions, local regulatory expertise and therapeutic leadership are designed to face the most difficult industry challenges across all major therapeutic areas including oncology, gastroenterology, nephrology and urology. We strive to improve the way clinical research is performed and impact the future of health care using the most advanced technology and a CHALLENGE ACCEPTED approach. In April 2021, Clinipace & dMed merged creating a differentiated mid-size CRO with the largest Asia-Pacific presence. We are proud to have such a strong group of global investors focused on improving healthcare outcomes and giving sponsors a better CRO choice. dMed`s 2019 acquisition of Target Health commenced the process of building a Next Generation global CRO for biotech and pharmaceutical companies. Our investors have invested over $230M to build the next great global CRO. dMed`s acquisition of Target Health in 2019 began dMed`s evolution from a local to global CRO. Target Health LLC is owned by dMedClinical Co. Ltd., a privately held company that is majority owned, operated, managed, and controlled by a U.S. citizen and foreign entities located in the People`s Republic of China. Dr. Lingshi Tan, is the aforementioned U.S. citizen currently residing in Shanghai, China. Dr. Tan moved to Shanghai (from New York) to become Pfizer`s VP of Worldwide Development Operations, and Chairman and General Manager of Pfizer (China) Research & Development Co. Dr. Tan founded dMed in 2016 to satisfy the local demand for a high quality, responsive, flexible CRO.

Posit Science Corporation

Posit Science Corporation is a San Francisco, CA-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Elara

Elara Caring is one of the nation`s largest providers of home-based care, with a national footprint in the Northeast, Midwest and Southwest. Elara brings together three award-winning organizations – Great Lakes Caring, National Home Health Care, and Jordan Health Services – into one transformational company, which provides the highest-quality comprehensive care continuum of personal care, skilled home health, and hospice care. The company is comprised of 32,500 caregivers serving over 65,000 patients and their families daily, in 225 locations across 16 states and focused on providing our patients with the “right care, at the right time, in the right place.”

MedBen

A leader in benefits management since 1938, MedBen excels in finding ways to help employer groups save money on their health care coverage. Our extensive service portfolio includes third party administration, consumer-driven products and worksite wellness.